Company news
Zydus Lifesciences Limited news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Press Release Jan 23 2026
January 23, 2026
Press Release Jan 22 2026
January 22, 2026
Zydus Lifesciences Limited Press Release Jan 22 2026
January 21, 2026
Press Release Jan 15 2026
January 15, 2026
Zydus Lifesciences Limited completes the acquisition of Agenus Inc.'s biologics manufacturing facilities, launches Zylidac Bio LLC in the U.S.
January 15, 2026
Press Release Jan 13 2026
January 13, 2026
Zydus Lifesciences Limited Press Release Jan 13 2026
January 12, 2026
Zydus Partners with Bioeq for U.S. Commercialisation rights for NUFYMCO(R), an Interchangeable Biosimilar to Lucentis(R)
December 24, 2025
Press Release Dec 23 2025
December 23, 2025
Zydus Partners with Bioeq for U.S. Commercialisation rights for NUFYMCO®, an Interchangeable Biosimilar to Lucentis®
December 23, 2025
Press Release Dec 19 2025
December 19, 2025
Zydus Lifesciences Limited Press Release Dec 19 2025
December 18, 2025
Press Release Dec 15 2025
December 15, 2025
Press Release Dec 10 2025
December 10, 2025
Press Release Dec 09 2025
December 9, 2025
Zydus and Formycon enter into an Exclusive Partnership for the Licensing and Supply of Biosimilar to Keytruda® (Pembrolizumab), in US and Canada
December 9, 2025
Press Release Dec 04 2025
December 4, 2025
Press Release Nov 27 2025
November 27, 2025
Press Release Nov 26 2025
November 26, 2025
Zydus and RK Pharma enter into an exclusive licensing and commercialization agreement for a novel 505(b)(2) product of supportive oncology treatment for the USA market
November 26, 2025
Press Release Nov 25 2025
November 25, 2025
Press Release Nov 14 2025
November 14, 2025
Press Release Nov 13 2025
November 13, 2025
Press Release Nov 11 2025
November 11, 2025
Zydus Lifesciences Limited Press Release Nov 11 2025
November 10, 2025
Press Release Nov 07 2025
November 7, 2025
Press Release Nov 06 2025
November 6, 2025
Press Release Nov 05 2025
November 5, 2025
Press Release Nov 04 2025
November 4, 2025
Press Release Oct 29 2025
October 29, 2025
Press Release Oct 24 2025
October 24, 2025
Press Release Oct 06 2025
October 6, 2025
Press Release Oct 01 2025
October 1, 2025
Press Release Sep 23 2025
September 23, 2025
Press Release Sep 21 2025
September 21, 2025
Zydus Lifesciences Limited Press Release Sep 21 2025
September 20, 2025
Press Release Sep 15 2025
September 15, 2025
Press Release Sep 05 2025
September 5, 2025
Press Release Sep 04 2025
September 4, 2025
Zydus and Synthon entered into exclusive licensing and supply agreement for Ozanimod Capsules (generic version of ZEPOSIA®) for the U.S. market
September 4, 2025
Press Release Sep 02 2025
September 2, 2025
Press Release Aug 29 2025
August 29, 2025
Zydus Therapeutics Reports Positive Topline Results from EPICS-III Phase 2(b)/3 Trial of Saroglitazar Magnesium in Patients with Primary Biliary Cholangitis
August 29, 2025
Press Release 20-08-2025 Newspaperadvertisement20082025
August 20, 2025
Press Release Aug 13 2025
August 13, 2025
Press Release Aug 12 2025
August 12, 2025
Press Release Aug 11 2025
August 11, 2025
Press Release Aug 08 2025
August 8, 2025
Press Release Aug 07 2025
August 7, 2025
Press Release Jul 29 2025
July 29, 2025
Decks
The 5 newest of 68 decks. Every deck is listed under its year.
- Q2 FY27 Earnings Presentation
Earnings · 16 slides · Nov 4, 2026
- Investor Presentation (August 2026)
Investor deck · 38 slides · Aug 23, 2026
- Q1 FY27 Earnings Presentation
Earnings · 17 slides · Aug 11, 2026
- Q4 FY26 Earnings Presentation
Earnings · 17 slides · May 19, 2026
- Q3 FY26 Earnings Presentation
Earnings · 16 slides · Feb 9, 2026